Replies to post #35664 on RespireRx Pharmaceuticals Inc (fka RSPI)

[aoe]

yes agree... so NEXT. what is next then? where funding could come from IF no partners?

btw, i don't think it is fair to kick mngt out, who's been keeping AMPAKINE from death. another reason is: those guys know more about the technology/AMPAKINE than us (at least myself), they may put their future/career/retirement on risky CORX :)

still tough ahead.

gl,
~aoe

[Market_Fest4]

Perhaps, what's really needed is an overhaul of the FDA process? The barriers to drug development are high cost and liability, which is typically shouldered by the U.S. population in the form of high drug prices before going generic. If the FDA could be encouraged to streamline the process, perhaps Cortex could get something going?
MF4